Dexmedetomidine in anesthesia for planned endovascular myocardial revascularization
https://doi.org/10.52420/2071-5943-2022-21-1-72-76
Abstract
Introduction. Endovascular stenting of coronary arteries is an effective, minimally invasive and rapidly developing method of coronary heart disease (CHD) treatment. The question regarding the choice of a drug for adequate and safe monitoring sedation in patients during this type of surgical procedures remains open. The aim of the study was to discuss a clinical case of dexmedetomidine in elective endovascular stenting of coronary arteries. Materials and methods. A clinical case of dexmedetomidine in anesthesia during elective stenting of the right coronary artery and its analgesic effect in the development of right coronary artery (RCA) dissection are described. Results. Patient S., 72 years old, after planned endovascular stenting of the right coronary artery with 3 stents at the time of his admission to the intensive care unit (ICU) had no angina pains and sternal discomfort. The patient was transferred to the specialized department 8 hours after stenting in a stable condition. Serum cardiospecific troponin T level was less than 0.2 ng/ml 6 hours after RCA stenting. No negative dynamics was described on the control ECG after surgical intervention. Discussion. Dexmedetomidine has a proven analgesic effect due to its direct effect on the peripheral nervous system. Conclusion. The use of dexmedetomidine has its place in periprocedural sedation in patients with coronary heart disease during planned endovascular coronary artery stenting, including patients with significant (over 90%) and extended coronary artery stenoses. The clinical use of dexmedetomidine in elective minimally invasive coronary interventions requires closer attention and study.
About the Authors
A. V. Tsarkov
Chelyabinsk Regional Clinical Hospital
Russian Federation
Russian Federation
Artem V. Tsarkov – anesthesiologist-intensivist.
Chelyabinsk.
A. L. Levit
Ural State Medical University
Russian Federation
Russian Federation
Aleksandr L. Levit – Doctor of Medicine.
Ekaterinburg.
References
1. Алекян Б.Г. et al. Рентгенэндоваскулярная диагностика и лечение заболеваний сердца и сосудов в Российской Федерации — 2019 год. // Эндоваскулярная хирургия. 2020. Vol. 7, № 2, Специальный выпуск. P. 5–230. DOI: 10.24183/2409-4080-2020-7-2S-S5-S230
2. Стабильная ишемическая болезнь сердца. Клинические рекомендации 2020 // Российский кардиологический журнал. 2020. Vol. 25, № 11. P. 201–250. DOI: 10.15829/1560-4071-2020-4076
3. Whitehead N.J. et al. Sedation and Analgesia for Cardiac Catheterisation and Coronary Intervention. // Hear. Lung Circ. 2020. Vol. 29, № 2. P. 169–177. DOI: 10.1016/j.hlc.2019.08.015
4. Hayman M., Forrest P., Kam P. Anesthesia for Interventional Cardiology. // J. Cardiothorac. Vasc. Anesth. 2012. Vol. 26, № 1. P. 134–147. DOI: 10.1053/j.jvca.2011.09.004
5. Song J.W., Soh S., Shim J.-K. Monitored Anesthesia Care for Cardiovascular Interventions. // Korean Circ. J. 2020. Vol. 50, № 1. P. 1–11. DOI: 10.4070/kcj.2019.0269
6. Practice Guidelines for Moderate Procedural Sedation and Analgesia 2018. // Anesthesiology. 2018. Vol. 128, № 3. P. 437–479. DOI: 10.1097/aln.0000000000002043
7. Дексдор инструкция по применению: показания, противопоказания, побочное действие — справочник препаратов и лекарств [Electronic resource]. URL: https://www.vidal.ru/drugs/dexdor33956 (accessed: 04.11.2021).
8. Kemp M.E.A. Anaesthesia and the cardiac catheterisation laboratory // South. African J. Anaesth. Analg. 2018. Vol. 24, № 3. P. S109–S113.
9. Tang C., Xia Z. Dexmedetomidine in perioperative acute pain management: a non-opioid adjuvant analgesic // J. Pain Res. Dove Press, 2017. Vol. 10. P. 1899. DOI: 10.2147/JPR.S139387
10. Овечкин А.М. et al. Дексмедетомидин как компонент анестезии и перспективная основа схем безопиоидной анальгезии // Регионарная анестезия и лечение острой боли. 2018. Vol. 12, № 2. P. 82–90. DOI: http://dx.doi.org/10.18821/1993-6508-2018-12-2-82-90
11. Grewal A. Dexmedetomidine: New avenues // J. Anaesthesiol. Clin. Pharmacol. Wolters Kluwer — Medknow Publications, 2011. Vol. 27, № 3. P. 297. DOI: 10.4103/0970-9185.83670
12. Sadjak A. et al. Periphere analgetische Wirkung durch intraartikulär verabreichtes Clonidin // Der Schmerz 2005 204. Springer, 2006. Vol. 20, № 4. P. 293–299. DOI: 10.1007/S00482-005-0448-1
13. Khasar S. et al. Peripheral nociceptive effects of alpha 2-adrenergic receptor agonists in the rat // Neuroscience. Neuroscience, 1995. Vol. 66, № 2. P. 427–432. DOI: 10.1016/0306-4522(94)00562-J
14. Liang F. et al. Dexmedetomidine attenuates neuropathic pain in chronic constriction injury by suppressing NR2B, NF-κB, and iNOS activation // Saudi Pharm. J. SPJ Off. Publ. Saudi Pharm. Soc. Saudi Pharm J, 2017. Vol. 25, № 4. P. 649–654. DOI: 10.1016/J.JSPS.2017.04.039
15. Schnabel A. et al. Is intraoperative dexmedetomidine a new option for postoperative pain treatment? A meta-analysis of randomized controlled trials // Pain. Pain, 2013. Vol. 154, № 7. P. 1140–1149. DOI: 10.1016/J.PAIN.2013.03.029
16. Mayr N.P. et al. Dexmedetomidine versus propofol-opioid for sedation in transcatheter aortic valve implantation patients: a retrospective analysis of periprocedural gas exchange and hemodynamic support // Can. J. Anaesth. Can J Anaesth, 2018. Vol. 65, № 6. P. 647–657. DOI: 10.1007/S12630-018-1092-4
17. Cristiano L. et al. Use of Dexmedetomidine in Transfemoral Transcatheter Aortic Valve Implantation (tf-TAVI) Procedures // Adv. Ther. Adv Ther, 2020. Vol. 37, № 5. P. 2337–2343. DOI: 10.1007/S12325-020-01342-W
18. Chen E.Y. et al. A Pilot Analysis of the Association Between Types of Monitored Anesthesia Care Drugs and Outcomes in Transfemoral Aortic Valve Replacement Performed Without General Anesthesia // J. Cardiothorac. Vasc. Anesth. J Cardiothorac Vasc Anesth, 2018. Vol. 32, № 2. P. 666–671. DOI: 10.1053/J.JVCA.2017.07.009
19. Ugata Y. et al. Periprocedural hypotension after conscious sedation versus local anesthesia during defibrillator implantation for left ventricular dysfunction: analysis of a national inpatient database in Japan // Heart Vessels. Heart Vessels, 2020. Vol. 35, № 1. P. 118–124. DOI: 10.1007/S00380-019-01462-6
Review
For citations:
Tsarkov AV, Levit AL. Dexmedetomidine in anesthesia for planned endovascular myocardial revascularization. Ural Medical Journal. 2022;21(1):72-76. (In Russ.) https://doi.org/10.52420/2071-5943-2022-21-1-72-76
Views:
208
Email this article 